Compounds > nevirapine

nevirapine and nbd 556

nevirapine has been researched along with nbd 556 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	3 (75.00)	2.80

Authors

Authors	Studies
Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Kurkin, AV; Kwon, YD; Kwong, PD; Ramesh, RR	1
Ahmed, S; Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Iusupov, IR; Kurkin, AV; Manasova, EV; Markov, PO; Spiridonov, EA	1
Arnold, E; Curreli, F; Das, K; Debnath, AK; Gruber, K; Losada, N; Pilch, A; Ruiz, FX	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1

Other Studies

4 other study(ies) available for nevirapine and nbd 556

Article	Year
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120. Journal of medicinal chemistry, 2017, 04-13, Volume: 60, Issue:7 Topics: Anti-HIV Agents; Biomimetic Materials; CD4 Antigens; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Pyrroles; Structure-Activity Relationship; Thiazoles; Virus Internalization	2017
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements. European journal of medicinal chemistry, 2021, Nov-15, Volume: 224 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Thiazoles; Virus Internalization	2021
HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites. Journal of medicinal chemistry, 2021, 11-25, Volume: 64, Issue:22 Topics: Allosteric Regulation; Anti-HIV Agents; Binding Sites; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Molecular Structure; Reverse Transcriptase Inhibitors; Structure-Activity Relationship	2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023